Reverse Engineering Clinical Success: Leveraging Sequencing Data & In Vitro Models to Decode TIL Therapy Mechanisms
Time: 9:00 am
day: Conference Day Two
Details:
- Providing an overview of CuraCell’s strategy to work backward from clinical outcomes of their TIL therapy
- Utilising TCR sequencing and advanced omics data to uncover the mechanisms of TIL therapy
- Applying findings to enhance in vitro strategies and refine therapeutic protocols
